(4) Adverse event costsExcluded because GLP-1 RA-related gastrointestinal symptoms are self-limited (medical intervention rate:1.2%3.5% [21]), and discontinuation rates were below significance thresholds in the SUSTAIN-7 trial [22]dulaglutide 2.4%, semaglutide 3.1%)
Investigators, Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono), Diabetes care, 35 (2012) 12251231
Eligibility varies by specific trial but generally includes adults with BMI 27-30, often with obesity-related comorbidities
5 Arithmetic mean serum enzymes values at Week 48
In the immediate post-operative recovery period, you are advised to take it easy and avoid strenuous activities such as vigorous exercise and lifting heavy objects